IP Library Granted Patent US 7,833,749
Granted Patent B2
US 7,833,749 · App. 10/572,175 · Granted Nov 16, 2010

Isolated photoprotein mtClytin, and use thereof

Assignee: Axxam S.p.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,749
App. No.
10/572,175
Granted
Nov 16, 2010
Kind
B2
Abstract

The invention relates to the photoprotein mtClytin, to its nucleotide and amino acid sequences and to the activity and use of the photoprotein mtClytin.

Claims (16)

1. An isolated nucleic acid molecule which is selected from the group consisting of:

a) a nucleic acid molecule which encodes a polypeptide which contains the amino acid sequence disclosed by SEQ ID NO: 2;

b) a nucleic acid molecule which contains the sequence depicted by SEQ ID NO: 1;

c) a nucleic acid molecule which exhibits a sequence identity along its full length with SEQ ID NO: 1 of at least 95% and encodes a polypeptide which has the biological function of a photoprotein; and

d) a nucleic acid molecule which exhibits a sequence identity along its full length with SEQ ID NO: 1 of at least 65% and encodes a polypeptide which has the biological function of a photoprotein.

2. The nucleic acid as claimed in claim 1 , further comprising a nucleic acid encoding a polypeptide other than that encoded by the nucleic acid of claim 1 , wherein a fusion gene is formed and wherein said fusion gene functions as a marker gene or reporter gene.

3. The nucleic acid as claimed in claim 1 , wherein said nucleic acid functions as a reporter gene in searching for pharmacologically active compounds.

4. The nucleic acid as claimed in claim 1 , which contains a functional promoter 5′ to its coding sequence.

5. A recombinant DNA or RNA vector which contains the nucleic acid as claimed in claim 4 .

6. An organism which harbors the vector as claimed in claim 5 .

7. An isolated polypeptide which is encoded by a nucleic acid sequence as claimed in claim 1 .

8. The polypeptide as claimed in claim 7 , wherein said polypeptide functions as a reporter protein in searching for pharmacologically active compounds.

9. The polypeptide of claim 7 , wherein said polypeptide is coupled to an additional protein.

10. The polypeptide of claim 9 , wherein said additional protein is selected from the group consisting of: an antibiotic, an enzyme, a receptor, an antibody and an ion channel.

11. A method for producing a polypeptide having phosphoprotein activity, said method comprising placing the nucleic acid of claim 1 into a bacteria, a viral system, yeast or a eukaryotic cell or in an in-vitro expression system under conditions that express said nucleic acid, and thereby producing said polypeptide.

12. A polypeptide encoded by the nucleic acid of claim 2 , wherein said polypeptide functions as a marker or reporter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2010
From: BAYER SCHERING PHARMA
To: AXXAM SPA
Reel/Frame 025138/0102 →
Priority Claims (1)
DE 103 42 670 · Sep 16, 2003 · national
Continuity (1)
Related Publication 20070275377A1 · Nov 29, 2007